EMD-16354

Single-particle
3.89 Å
EMD-16354
3D View Gallery
Deposition: 15/12/2022
Map released: 22/03/2023
Last modified: 24/07/2024
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-16354

Archive Files (Depositor)

Primary 3D volume (map.gz) Half-map 1 Half-map 2 (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz) Map-8c03 summary report (pdf.gz) Map-8c03 FULL report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

EMDB Files

VA raw map (map) VA resolution mask (mrc)

Structure of SLC40/ferroportin in complex with vamifeport and synthetic nanobody Sy12 in outward-facing conformation

EMD-16354

Single-particle
3.89 Å
EMD-16354
3D View Gallery
Deposition: 15/12/2022
Map released: 22/03/2023
Last modified: 24/07/2024
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Homo sapiens
Sample: Complex of ferroportin with synthetic nanobody and inhibitor
Fitted models: 8c03

Deposition Authors: Lehmann EF , Liziczai M , Drozdzyk K , Dutzler R , Manatschal C
Structures of ferroportin in complex with its specific inhibitor vamifeport.
Lehmann EF , Liziczai M , Drozdzyk K , Altermatt P, Langini C, Manolova V, Sundstrom H, Durrenberger F , Dutzler R , Manatschal C
(2023) eLife , 12
PUBMED: 36943194
DOI: doi:10.7554/eLife.83053
ISSN: 2050-084X
Grant Support: